Our analysis showed strong gene compensation across cancer types (Fig. 5b), and ORF screens pointed to RBM14 overexpression also leading to detrimental effects on cell proliferation in multiple cancer types (Fig. 5c). This evidence concerns the gene RBM14 and cancer.